Home › AbbVie predicts sharp increase in earnings
 

Keywords :   


AbbVie predicts sharp increase in earnings

2015-01-09 07:00:01| Biotech - Topix.net

AbbVie Inc. predicted sharply higher earnings for the new year, driven by rheumatoid-arthritis drug Humira and the launch of its new hepatitis C virus treatment. The U.S. Food and Drug Administration last month approved the pharmaceutical company's Viekira Pak, an all-oral cocktail of several drugs that showed strong success in treating the liver disease in clinical trials.

Tags: increase sharp earnings predicts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »